Filing Details

Accession Number:
0001181431-13-030546
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-24 14:13:36
Reporting Period:
2013-05-22
Filing Date:
2013-05-24
Accepted Time:
2013-05-24 14:13:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1183765 Threshold Pharmaceuticals Inc THLD Pharmaceutical Preparations (2834) 943409596
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542778 Tillman Pearce 170 Harbor Way, Suite 300
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-22 20,000 $3.46 20,000 No 4 M Direct
Common Stock Disposition 2013-05-22 20,000 $5.63 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-02-16 20,000 $0.00 20,000 $3.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
230,000 2022-02-16 No 4 M Direct
Footnotes
  1. 25% of the shares underlying the Option shall vest and become exercisable on February 16, 2013. Thereafter the remaining shares will vest and become exercisable at a rate of 1/36th per month.